Suzhou Youseen New Drug R&D

Suzhou Youseen New Drug R&D is a Chinese biopharmaceutical company specializing in the modernization and industrialization of Traditional Chinese Medicine (TCM) and natural products. Founded in 2003 by Professor Xuan Zhenyu, the company focuses on developing innovative Class 1.1 TCM therapies for infectious diseases, cardiovascular conditions, and neurological disorders. Its lead candidate, Qinghouyan Guccal Tablets, is in Phase 3 clinical trials for acute pharyngitis, while other programs such as Catalpol and various herbal granules are in Phase 1 and 2 for indications like ischemic stroke and pediatric respiratory infections. Headquartered in Suzhou with R&D facilities in Shanghai and a manufacturing site in Lingang, the company integrates traditional herbal knowledge with modern pharmaceutical standards to address unmet medical needs.